Archives: Financing

Paired to the launch of the Lancet NCDI Poverty Commission report in September 2020, this policy brief provides a high level overview of the findings and recommendations from the Commission report, as part of efforts to address one of the most glaring inequities in global health.

Released by The Lancet Commission on Reframing NCDs and Injuries for the Poorest Billion (The Lancet NCDI Poverty Commission) in September 2020, this landmark report highlights key findings and recommendations demonstrating the magnitude and pattern of the NCDI burden in several low and low-middle income countries (LLMICs) in Sub-Saharan Africa, the Caribbean, and South Asia as well as emphasizing the disparities existing in care and resources available for NCDs and injuries.

This commentary discusses of the impact of COVID-19 on type 1 diabetes (T1D) care in low-middle income countries (LMICs), due to the exacerbations of COVID on access to insulin, blood glucose monitoring, and availability of expert clinical care. Through various country examples, the authors describes these challenges and their evolving responses.

This study examines the cost of organizing integrated nurse-driven, physician-supervised chronic care for more severe NCDs at an outpatient specialty clinic associated with a district hospital in rural Rwanda. This study concludes that high levels of service for severe, chronic diseases are achievable at a relatively low cost for lower income countries.

From 2017-2020, Partners In Health will be collaborating with Helmsley Charitable Trust on a $12 million partnership to support increased access to type 1 diabetes and integrated NCD care across four PIH sites in sub-Saharan Africa and Haiti.

This article reviews the funding landscape of NCDs to date, showcasing the key NCD funders globally and articulating the reasons donors shy away from making major investments in NCD prevention and control. The author, Rachel Nugent, offers actionable next steps for the global health community going into the UN High Level Meeting in 2018.

Despite over 45 years of recognition as a public health concern, chronic diseases remain largely sidelined in donor financing and academic pursuits. This article explores this relationship and offers next steps for the emergence of relevant global public health.

Published in December 2015 by the Frederick S. Pardee Center at Boston University, this report examines the ways in which the global HIV/AIDS movement can inform the future of political advocacy, funding, and treatment delivery for cancer and non-communicable diseases in sub-Saharan Africa.

Watch Dr. Paul Farmer discuss the challenges of NCD and Injury care, and announce PIH's commitment to a new Lancet commission focused on NCDs and injuries of the poorest billion people. This commission aims to mend a great disparity in health and to broaden the current noncommunicable disease agenda in the interest of equity.

This article discusses the economic and health systems dimensions of global childhood cancer outcomes, using access to medicines as an example of barriers to care. Authors also make a call to improve investment in research that explores the intersections between childhood cancer and health systems in low- and middle-income countries.